Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study.
Male or female.
Age 18 64 years (both inclusive) at the time of signing the informed consent.
Body weight between 60.0 and 100.0 kilogram (kg) (both inclusive) at screening.
Body mass index between 18.5-29.9 kilograms per square meter (kg/m\^2) (both inclusive).
Considered to be generally healthy based on the medical history, physical examination, and the results of vital signs, electrocardiogram and clinical laboratory tests performed during the screening visit, as judged by the investigator.
You may not be if
Platelet count greater than (\>) 400\*10\^9/ Liter (L) at visit 1
Absolute neutrophil count less than or equal to (≤) 1.5\*10\^9/L at visit 1
Female who is:
1. pregnant, breast-feeding or intends to become pregnant during the trial or within 6 months after the last dose of trial product or
2. of childbearing potential and not using highly effective contraceptive method and whose male partner is not using effective contraception, from screening until 6 months after the last dose of trial product
Male of reproductive age with female partner of childbearing potential who does not agree to use condoms and whose female partner of childbearing potential is not using a highly effective contraceptive measure (or adequate contraceptive measure as required by local regulation or practice) from signing the informed consent form (ICF) until 6 months after the last dose.
